Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gibbons

Showing results (61-70 of 278) with videos related to

Pageof 28
Sort By:
Access Microbiology|January 13, 2022
The ChpR transcriptional regulator of <i>Sinorhizobium meliloti</i> senses 3,5,6-trichloropyridinol, a degradation product of the organophosphate pesticide chlorpyrifosNathan D McDonald, Courtney E Love, Henry S Gibbons
Infection and Immunity|February 21, 2002
Discordance between T-cell receptor expression and effector function in mice infected with Histoplasma capsulatumGeorge S Deepe, Reta S Gibbons, Susan R Ward
Spinal Cord Series and Cases|January 6, 2017
FES-rowing attenuates bone loss following spinal cord injury as assessed by HR-pQCTRobin S Gibbons, Gary S Beaupre, Galateia J Kazakia
International Journal of Environmental Research and Public Health|December 22, 2023
Upper Airway-Related Symptoms According to Mental Illness and Sleep Disorders among Workers Employed by a Large Non-Profit Organization in the Mountain West Region of the United StatesRay M Merrill, Ian S Gibbons, Christian J Barker
The Journal of Biological Chemistry|August 12, 2004
MsbA-dependent translocation of lipids across the inner membrane of Escherichia coliWilliam T Doerrler, Henry S Gibbons, Christian R H Raetz
British Journal of Clinical Pharmacology|December 1, 1996
Improved tolerability of ritonavir derived from pharmacokinetic principlesC Merry, M Barry, S Gibbons, et al.
AIDS (London, England)|February 1, 1997
Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV diseaseC Merry, F Mulcahy, M Barry, et al.
Clinical Pharmacokinetics|May 13, 1999
Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infectionM Barry, F Mulcahy, C Merry, et al.
Diseases of the Colon and Rectum|May 1, 1991
Survival after resection of carcinoma of the splenic flexureD H Levien, S Gibbons, D Begos, et al.
Therapeutic Drug Monitoring|January 1, 1990
Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrationsJ Grevel, K L Napoli, S Gibbons, et al.
Pageof 28

Showing results (61-70 of 278) with videos related to

Sort By:
Pageof 28
Access Microbiology|January 13, 2022
The ChpR transcriptional regulator of <i>Sinorhizobium meliloti</i> senses 3,5,6-trichloropyridinol, a degradation product of the organophosphate pesticide chlorpyrifosNathan D McDonald, Courtney E Love, Henry S Gibbons
Infection and Immunity|February 21, 2002
Discordance between T-cell receptor expression and effector function in mice infected with Histoplasma capsulatumGeorge S Deepe, Reta S Gibbons, Susan R Ward
Spinal Cord Series and Cases|January 6, 2017
FES-rowing attenuates bone loss following spinal cord injury as assessed by HR-pQCTRobin S Gibbons, Gary S Beaupre, Galateia J Kazakia
International Journal of Environmental Research and Public Health|December 22, 2023
Upper Airway-Related Symptoms According to Mental Illness and Sleep Disorders among Workers Employed by a Large Non-Profit Organization in the Mountain West Region of the United StatesRay M Merrill, Ian S Gibbons, Christian J Barker
The Journal of Biological Chemistry|August 12, 2004
MsbA-dependent translocation of lipids across the inner membrane of Escherichia coliWilliam T Doerrler, Henry S Gibbons, Christian R H Raetz
British Journal of Clinical Pharmacology|December 1, 1996
Improved tolerability of ritonavir derived from pharmacokinetic principlesC Merry, M Barry, S Gibbons, et al.
AIDS (London, England)|February 1, 1997
Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV diseaseC Merry, F Mulcahy, M Barry, et al.
Clinical Pharmacokinetics|May 13, 1999
Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infectionM Barry, F Mulcahy, C Merry, et al.
Diseases of the Colon and Rectum|May 1, 1991
Survival after resection of carcinoma of the splenic flexureD H Levien, S Gibbons, D Begos, et al.
Therapeutic Drug Monitoring|January 1, 1990
Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrationsJ Grevel, K L Napoli, S Gibbons, et al.
Pageof 28